SCHEMBL6204426

SCHEMBL6204426

COc1ccc(CC([O])OC)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 1/20 0.58
SLC6A4 P31645 1/20 0.57
CYP1A2 P05177 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C19 P33261 1/20 0.53
IDO1 P14902 2/20 0.48
POLB P06746 1/20 0.46
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
CA14 Q9ULX7 1/20 0.46
CMA1 P23946 1/20 0.46
AGXT P21549 1/20 0.45
LTA4H P09960 1/20 0.45
TAAR1 Q96RJ0 1/20 0.45
PPARG P37231 1/20 0.45
PPARA Q07869 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6204601 0.81 PKM (0.41) LDHASLC6A4CYP1A2IDO1CA1
SCHEMBL1070963 0.80 SLC6A4 (0.63) LDHASLC6A4CYP1A2CYP2D6CYP2C19
SCHEMBL11538137 0.79 SLC6A4 (0.57) LDHASLC6A4CYP1A2CYP2D6CYP2C19
SCHEMBL6205901 0.79 TRPA1 (0.46) IDO1CA12CA7CA9CA14
SCHEMBL1357677 0.78 TAAR1 (0.46) SLC6A4CYP1A2CYP2D6TAAR1PPARG
SCHEMBL6204551 0.77 TAAR1 (0.64) IDO1CMA1AGXTTAAR1SMN1; SMN2
SCHEMBL15514667 0.77 LTA4H (0.53) LDHASLC6A4CYP1A2CYP2D6CYP2C19
SCHEMBL8933391 0.77 SLC6A4 (0.64) LDHASLC6A4CYP1A2CYP2D6CYP2C19
SCHEMBL29018022 0.77 LDHA (0.60) LDHASLC6A4CYP1A2CYP2D6CYP2C19
SCHEMBL10897973 0.76 SLC6A4 (0.53) LDHASLC6A4CYP1A2CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO disclosed